We feel now is a pretty good time to analyse Bausch Health Companies Inc.’s (NYSE:BHC) business as it appears the company may be on the cusp of a considerable accomplishment. Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. The US$3.2b market-cap company announced a latest loss of US$592m on 31 December 2023 for its most recent financial year result. As path to profitability is the topic on Bausch Health Companies’ investors mind, we’ve decided to gauge market sentiment. In this article, we will touch on the expectations for the company’s growth and when analysts expect it to become profitable.
See our latest analysis for Bausch Health Companies
According to the 6 industry analysts covering Bausch Health Companies, the consensus is that breakeven is near. They expect the company to post a final loss in 2023, before turning…
